Bank of America’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,720
| Closed | -$148 | – | 8406 |
|
|
2023
Q3 | $148 | Hold |
1,720
| – | – | ﹤0.01% | 7438 |
|
|
2023
Q2 | $963 | Hold |
1,720
| – | – | ﹤0.01% | 7253 |
|
|
2023
Q1 | $1.96K | Hold |
1,720
| – | – | ﹤0.01% | 7225 |
|
|
2022
Q4 | $1.93K | Hold |
1,720
| – | – | ﹤0.01% | 7252 |
|
|
2022
Q3 | $4K | Buy |
1,720
+1,719
| +171,900% | +$3.34K | ﹤0.01% | 7467 |
|
|
2022
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 8595 |
|
|
2022
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 8971 |
|
|
2021
Q4 | $0 | Sell |
1
-6,213
| -100% | -$10.1K | ﹤0.01% | 8829 |
|
|
2021
Q3 | $18K | Buy |
6,214
+3,463
| +126% | +$11.6K | ﹤0.01% | 7428 |
|
|
2021
Q2 | $8K | Sell |
2,751
-59,258
| -96% | -$181K | ﹤0.01% | 7359 |
|
|
2021
Q1 | $202K | Buy |
62,009
+56,104
| +950% | +$231K | ﹤0.01% | 6037 |
|
|
2020
Q4 | $24K | Sell |
5,905
-52,885
| -90% | -$305K | ﹤0.01% | 6551 |
|
|
2020
Q3 | $318K | Buy |
58,790
+47,095
| +403% | +$271K | ﹤0.01% | 5022 |
|
|
2020
Q2 | $79K | Buy |
11,695
+8,707
| +291% | +$42.6K | ﹤0.01% | 5788 |
|
|
2020
Q1 | $9K | Sell |
2,988
-9,301
| -76% | -$49.5K | ﹤0.01% | 6399 |
|
|
2019
Q4 | $86K | Buy |
12,289
+7,713
| +169% | +$41.2K | ﹤0.01% | 6056 |
|
|
2019
Q3 | $17K | Sell |
4,576
-3,647
| -44% | -$12.4K | ﹤0.01% | 6623 |
|
|
2019
Q2 | $31K | Buy |
8,223
+6,275
| +322% | +$20.9K | ﹤0.01% | 6470 |
|
|
2019
Q1 | $7K | Sell |
1,948
-2,184
| -53% | -$16.1K | ﹤0.01% | 6746 |
|
|
2018
Q4 | $31K | Buy |
+4,132
| New | +$33.1K | ﹤0.01% | 6374 |
|
Other funds holding RVLP
Bank of America's RVLP Position: Q4 2023 in Review
Bank of America sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q4 2023, closing a stake of 1,720 shares — an estimated $148 sold.
Bank of America first reported a position in RVLP in Q4 2018 and held it in 20 quarters. The position peaked at $318K in Q3 2020. 3 funds tracked by Wall St. Rank hold RVLP as of Q4 2023.
- Bank of America reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q4 2023 after selling out during the quarter.
- Bank of America sold 1,720 RVL Pharmaceuticals plc Ordinary Shares shares in Q4 2023, an estimated $148.
- Bank of America first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q4 2018 and held it in 20 quarters.
- Bank of America's RVL Pharmaceuticals plc Ordinary Shares position peaked at $318K in Q3 2020.
- 3 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q4 2023.
Based on Bank of America's 13F filing for Q4 2023, filed 14 Feb 2024.